Prosecution Insights
Last updated: October 22, 2026
Application No. 18/893,187

CUSTOMIZABLE WOUND CLOSURE DEVICE AND METHOD OF USE

Non-Final OA §103§DP
Filed
Sep 23, 2024
Priority
Jul 27, 2017 — provisional 62/537,617 +3 more
Examiner
ARBLE, JESSICA R
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Smith & Nephew plc
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
273 granted / 410 resolved
-3.4% vs TC avg
Strong +25% interview lift
Without
With
+25.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
466
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
50.1%
+10.1% vs TC avg
§102
19.3%
-20.7% vs TC avg
§112
24.6%
-15.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 410 resolved cases

Office Action

§103 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 31, 32, 34-44, 46, 47, 49, and 50 is/are rejected under 35 U.S.C. 103 as being unpatentable over Greener et al (US 2011/0319804) in view of Kuzmin (US 2009/0117311). Regarding Claim 31, Greener discloses a wound closure device (¶ [0001-0005]) comprising: a plurality of segments (individual cubic portions 12, Figs. 4 and 5) configured to be attached to each other to form an assembled structure (body 10, Figs. 4 and 5; the cubic portions are attached to each other through frangible regions 20; although the building blocks are manufactured attached to one another, they still read on the claims as written as the building blocks are not required to be separate prior to attachment) configured for placement in a wound (¶ [0074]; the body is used as wound packing); and wherein individual segments (12, Figs. 4 and 5) comprise a plurality of walls (as seen in Figs. 4 and 5, the each segment is cuboidal with 6 walls). Greener is silent whether each segment comprises an attachment element, the segment reversibly securable to the assembled structure such that the segment is configured to be removed from the assembled structure and re-secured to the assembled structure by the attachment element. Kuzmin teaches interlocking elements, thus being in the same field of endeavor of modular building blocks, where each cell (block as seen in Fig. 20) comprises an attachment element (protrusions, Fig. 20) on a wall of a cell (Fig. 20; the actual cube portion is the cell), the cell reversibly securable to the assembled structure such that the cell is configured to be removed from the assembled structure and re-secured to the assembled structure by the attachment element (¶ [0010, 0113]). The blocks of Kuzmin allow for easy attachment and detachment while also providing a strong assembled construction (¶ [0164]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the shape of the segments of Greener to be the shape of the segments of Kuzmin Fig. 20 to comprise an attachment element positioned on the segment, the segment able to be removed from the assembled structure and re-secured to the assembled structure by the attachment element, as taught by Kuzmin (Fig. 20). Kuzmin states that the attachment structures provide for easy attachment and detachment of blocks while still providing for a strong assembled construction (¶ [0164]), which would improve the customization of the dressing of Greener by allowing segments to be removed and reattached as needed without negatively impacting the strength of the assembled device. Regarding Claim 32, the combination of Greener/Kuzmin, as set forth above for Claim 31, teaches that the one or more building segments (cubic portions 12 of Greener that have been modified to have the shape, and therefore the protrusions and depressions, of Kuzmin Fig. 20) comprises receiving elements (depressions, Fig. 20 of Kuzmin) configured to receive the attachment elements (protrusions, Fig. 20 of Kuzmin) of one or more of the building blocks (12, Fig. 4, Greener; Fig. 20, Kuzmin; ¶ [0010, 0113, 0164] of Kuzmin). Regarding Claim 34, Greener further discloses individual segments (12, Figs. 4 and 5) comprise one or more cells (12, Figs. 4 and 5) provided in a single row (each segment is comprised of one cell that can be interpreted as in a single row). Regarding Claim 35, Greener further discloses individual segments (12, Figs. 4 and 5) comprise a cell (12, Figs. 4 and 5) having a uniform shape and size (each segment is the same size cube). Regarding Claim 36, Greener further discloses individual segments (12, Figs. 4 and 5) consist of one cell (12, Figs. 4 and 5). Regarding Claim 37, Greener further discloses individual segments (12, Figs. 4 and 5) comprise at least one cell having a quadrilateral shape (a cube is formed by 6 square sides, and each square is a quadrilateral). Regarding Claim 38, Greener further discloses individual segments (12, Figs. 4 and 5) comprise a porous material (¶ [0072]). Regarding Claim 39, Greener further discloses individual segments (12, Figs. 4 and 5) comprise foam (¶ [0072]). Regarding Claim 40, Greener further discloses individual segments (12, Figs. 4 and 5) comprise precuts (14, 16, 18, Figs. 4 and 5) defining frangible portions (20, Figs. 4 and 5). Regarding Claim 41, Greener further discloses one individual segments (12, Figs. 4 and 5) are configured to be cut or torn (¶ [0076] removing by hand is tearing away). Regarding Claims 42-44, Greener further discloses a source of negative pressure, a drape, and a port, where the port is configured to transmit negative pressure through the drape placed over the wound (¶ [0003-0005]; the body 10 can be used with NPWT which uses a negative pressure source and a drape). Regarding Claim 46, Greener discloses a method of closing a wound (¶ [0001-0005]), comprising: positioning an assembled structure (10, Figs. 4 and 5) within a wound (¶ [0074]), the assembled structure (10, Figs. 4 and 5) comprising a plurality of segments (12, Figs. 4 and 5) configured to be attached to each other (each segment is attached to one another during manufacturing); and wherein individual segments (12, Figs. 4 and 5) comprise a plurality of walls (as seen in Figs. 4 and 5, each segment is cuboidal with 6 walls). Greener is silent whether each segment comprises an attachment element, the segment reversibly securable to the assembled structure such that the segment is configured to be removed from the assembled structure and re-secured to the assembled structure by the attachment element. Kuzmin teaches interlocking elements, thus being in the same field of endeavor of modular building blocks, where each cell (block as seen in Fig. 20) comprises an attachment element (protrusions, Fig. 20) on the cell (Fig. 20; the actual cube portion is the cell), the cell reversibly securable to the assembled structure such that the cell is configured to be removed from the assembled structure and re-secured to the assembled structure by the attachment element (¶ [0010, 0113]). The blocks of Kuzmin allow for easy attachment and detachment while also providing a strong assembled construction (¶ [0164]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the shape of the segments of Greener to be the shape of the segments of Kuzmin Fig. 20 to comprise an attachment element positioned on the segment, the segment able to be removed from the assembled structure and re-secured to the assembled structure by the attachment element, as taught by Kuzmin (Fig. 20). Kuzmin states that the attachment structures provide for easy attachment and detachment of blocks while still providing for a strong assembled construction (¶ [0164]), which would improve the customization of the dressing of Greener by allowing segments to be removed and reattached as needed without negatively impacting the strength of the assembled device. Regarding Claim 47, the combination of Greener/Kuzmin, as set forth above for Claim 46, teaches that the one or more building segments (cubic portions 12 of Greener that have been modified to have the shape, and therefore the protrusions and depressions, of Kuzmin Fig. 20) comprises receiving elements (depressions, Fig. 20 of Kuzmin) configured to receive the attachment elements (protrusions, Fig. 20 of Kuzmin) of one or more of the building blocks (12, Fig. 4, Greener; Fig. 20, Kuzmin; ¶ [0010, 0113, 0164] of Kuzmin). Regarding Claim 49, Greener further discloses individual segments (12, Figs. 4 and 5) comprise one or more cells (12, Figs. 4 and 5) provided in a single row (each segment is comprised of one cell that can be interpreted as in a single row). Regarding Claim 50, Greener further discloses individual segments (12, Figs. 4 and 5) comprise a cell (12, Figs. 4 and 5) having a uniform shape and size (each segment is the same size cube). Claims 33, 45, and 48 are rejected under 35 U.S.C. 103 as being unpatentable over Greener et al (US 2011/0319804) in view of Kuzmin (US 2009/0117311) further in view of Saxby (WO 2015/110409). Regarding Claims 33 and 48, Greener/Kuzmin is silent whether each of the segments has an elongate shape with a uniform width. Saxby teaches a wound filler made of repeating units (302, Fig. 5A) which have an elongate shape with a uniform width (as seen in Fig. 5A). Therefore, it would have been obvious to substitute the shape of the segments of Greener/Kuzmin for the elongate shape with uniform width of Saxby, as Saxby shows that wound fillers made with elongate, repeating units were known in the art. This would result in a rectangular prism shaped building unit rather than the cuboidal shaped building unit of Greener/Kuzmin. Regarding Claim 45, Greener/Kuzmin is silent regarding an organ protection layer. Saxby teaches a wound filler with an organ protection layer (¶ [0147]) which protects the bottom layer of the wound from the negative pressure applied to the wound filler (¶ [0147]). Therefore, it would have been obvious to modify the wound filler of Greener/Kuzmin to include an organ protection layer, as motivated by Saxby, to protect the bottom layer of the wound from the negative pressure applied to the wound filler (as motivated by Saxby ¶ [0147]). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 31-47 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 and 20 of U.S. Patent No. 12,097,096. Although the claims at issue are not identical, they are not patentably distinct from each other because the patented claims are merely narrower than the pending claims (since the patented claims recite the attachment element located on the wall and an opening extending through the top and bottom ends of the segments), making the patented claims a species of the pending claims’ genus. Since it has been held that the species anticipates the genus, the patented claims anticipate the pending claims. Claims 31-46 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 3-16 of U.S. Patent No. 11,607,344. Although the claims at issue are not identical, they are not patentably distinct from each other because the patented claims are merely narrower than the pending claims (since the patented claims recite the attachment element located on the wall and an opening extending through the top and bottom ends of the segments, as well as referring to the segments as building blocks or building units and indicating that the assembled structure exhibits anisotropic behavior), making the patented claims a species of the pending claims’ genus. Since it has been held that the species anticipates the genus, the patented claims anticipate the pending claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jessica Arble whose telephone number is (571)272-0544. The examiner can normally be reached Mon - Fri 9 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at 571-272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA ARBLE/ Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Sep 23, 2024
Application Filed
Oct 01, 2026
Non-Final Rejection mailed — §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766296
DEVICES AND METHODS FOR DELIVERY OF PHARMACEUTICAL COMPOSITIONS
1y 11m to grant Granted Oct 20, 2026
Patent 12758432
NEGATIVE-PRESSURE THERAPY DRESSING WITH FLUID TRANSPORT FEATURES
3y 2m to grant Granted Oct 13, 2026
Patent 12740899
PERSONAL HYGIENE PRODUCT
4y 7m to grant Granted Sep 22, 2026
Patent 12741071
BLOOD RESERVOIR WITH BLOOD-HANDLING ASSEMBLY
2y 2m to grant Granted Sep 22, 2026
Patent 12702524
TEMPLATE AND METHOD FOR REMOVING A TATTOO THROUGH PATTERNED TRANS-EPIDERMAL PIGMENT RELEASE
5y 8m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
92%
With Interview (+25.0%)
3y 4m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 410 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month